{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:24Z","timestamp":1767134904568,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd006403","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T00:00:00Z","timestamp":1239753600000}}],"reference-count":33,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006403.pub2","type":"journal-article","created":{"date-parts":[[2009,4,15]],"date-time":"2009-04-15T15:00:11Z","timestamp":1239807611000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vaccines for preventing anthrax"],"prefix":"10.1002","author":[{"given":"Sarah","family":"Donegan","sequence":"first","affiliation":[{"name":"Liverpool School of Tropical Medicine; International Health Group; Pembroke Place Liverpool Merseyside UK L3 5QA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bellamy","sequence":"additional","affiliation":[{"name":"James Cook University Hospital; Department of Infection and Travel Medicine; Marton Road Middlesbrough UK TS4 3BW"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrol L","family":"Gamble","sequence":"additional","affiliation":[{"name":"University of Liverpool; Centre for Medical Statistics and Health Evaluation; Shelley's Cottage Brownlow Street Liverpool UK L69 3GS"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,15]]},"reference":[{"key":"10.1002\/14651858.CD006403.pub2-BIB0001|cit1","first-page":"27","article-title":"Epidemiological efficacy of the anthrax STI vaccine","volume":"9","author":"Burgasov","year":"1976","journal-title":"Zhurnal Mikrobiologii, Epidemiologii i Immunobiologii"},{"issue":"5","key":"10.1002\/14651858.CD006403.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4161\/hv.3.5.4459","article-title":"Safety, reactogenicity and immunogenicity of a recombinant protective antigen anthrax vaccine given to healthy adults","volume":"3","author":"Campbell","year":"2007","journal-title":"Human Vaccines"},{"issue":"33-34","key":"10.1002\/14651858.CD006403.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1016\/j.vaccine.2006.05.044","article-title":"Immunogenicity and tolerance of ascending doses of a recombinant protective antigen (rPA102) anthrax vaccine: A randomized, double-blinded, controlled, multicenter trial","volume":"24","author":"Gorse","year":"2006","journal-title":"Vaccine"},{"issue":"13","key":"10.1002\/14651858.CD006403.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1001\/jama.300.13.1532","article-title":"Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trial","volume":"300","author":"Marano","year":"2008","journal-title":"JAMA"},{"issue":"9-10","key":"10.1002\/14651858.CD006403.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD006403.pub2-BIB0006|cit6","first-page":"632-45","article-title":"Field evaluation of a human anthrax vaccine","volume":"52","author":"Brachman","year":"1962","journal-title":"American Journal of Public Health"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0007|cit7","first-page":"1","volume-title":"A comparative study of humoral anti-anthrax immunity in animals and humans immunized with live and chemical vaccines, UDK","author":"Derbin","year":"1981"},{"issue":"18","key":"10.1002\/14651858.CD006403.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1016\/j.vaccine.2007.01.056","article-title":"Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine","volume":"25","author":"Grunow","year":"2007","journal-title":"Vaccine"},{"issue":"32","key":"10.1002\/14651858.CD006403.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1016\/j.vaccine.2007.05.018","article-title":"Immune response to two different dosing schedules of the anthrax vaccine precipitated (AVP) vaccine","volume":"25","author":"Hepburn","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD006403.pub2-BIB0010|cit10","first-page":"133","article-title":"Delayed hypersensitivity after anthrax vaccination. II. Delayed hypersensitivity in humans vaccinated against anthrax","volume":"54","author":"Shlyakhov","year":"1994","journal-title":"Medecine Tropicale"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0011|cit11","first-page":"51","article-title":"Assessment of immunity and allergy after vaccination with dry combined anthrax vaccine","volume":"5","author":"Shevtsov","year":"2007","journal-title":"Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0012|cit12","unstructured":"NCT00057525 A Phase 1 study of safety and immunogenicity of e. coli-derived recombinant protective antigen (rPA), a new anthrax vaccine administered by the intramuscular (IM) route in healthy adults clinicaltrials.gov\/ct2\/show\/NCT00057525"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0013|cit13","unstructured":"NCT00063843 A Phase I, dose-escalating study to assess the safety, tolerability, and immunogenicity of recombinant anthrax protective antigen vaccine (rPA) administered in two intramuscular doses to healthy adults clinicaltrials.gov\/ct2\/show\/NCT00063843"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0014|cit14","unstructured":"NCT00100724 A Phase 2 multi-center, randomized dose-finding trial of rPA-102 vaccine in healthy adult volunteers clinicaltrials.gov\/ct2\/show\/NCT00100724"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0015|cit15","unstructured":"NCT00103467 A Phase 1 trial to evaluate the safety and immunogenicity of an anthrax recombinant protective antigen vaccine clinicaltrials.gov\/ct2\/show\/NCT00103467"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0016|cit16","unstructured":"NCT00114621 Anthrax vaccine clinical trials clinicaltrials.gov\/ct2\/show\/NCT00114621"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0017|cit17","unstructured":"Marano N Babcock J Keitel W Keyserling H Parker S Poland P Interim analysis of anthrax vaccine human reactogenicity and immunogenicity clinical trial Personal correspondence (email)"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0018|cit18","unstructured":"NCT00119067 Anthrax vaccine adsorbed: human reactogenicity and immunogenicity trial to address change in route of administration and dose reduction clinicaltrials.gov\/ct2\/show\/NCT00119067"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0019|cit19","unstructured":"NCT00133484 A Phase II study to assess the safety, tolerability, immunogenicity, and optimal primary schedule of 3 recombinant protective antigen (rPA) anthrax vaccines administered in two intramuscular doses to healthy adults clinicaltrials.gov\/ct2\/show\/NCT00133484"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0020|cit20","unstructured":"NCT00170456 A double-blind, parallel-group study of the safety, tolerability and immunogenicity of a range of doses and dosing schedules of Recombinant (rPA Based) Anthrax Vaccine in healthy subjects clinicaltrials.gov\/ct2\/show\/NCT00170456"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0021|cit21","unstructured":"NCT00170469 A Phase II, dose ranging multi-centre, single blind, parallel-group, controlled study of the safety, tolerability and immunogenicity of recombinant (rPA based) anthrax vaccine compared with anthrax vaccine adsorbed in a healthy population clinicaltrials.gov\/ct2\/show\/NCT00170469"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0022|cit22","unstructured":"Centers for Disease Control and Prevention (CDC) What is the anthrax vaccine? www.cdc.gov\/ncidod\/dbmd\/diseaseinfo\/anthrax_g.htm#whatisvacc"},{"issue":"11","key":"10.1002\/14651858.CD006403.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJM199909093411107","article-title":"Anthrax","volume":"341","author":"Dixon","year":"1999","journal-title":"New England Journal of Medicine"},{"issue":"17","key":"10.1002\/14651858.CD006403.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1001\/jama.287.17.2236","article-title":"Anthrax as a biological weapon, 2002: updated recommendations for management","volume":"287","author":"Inglesby","year":"2002","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0025|cit25","doi-asserted-by":"crossref","DOI":"10.21236\/ADA403352","volume-title":"The anthrax vaccine. Is it safe? Does it work?","author":"Jollenbeck","year":"2002"},{"issue":"7303","key":"10.1002\/14651858.CD006403.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0027|cit27","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 (updated February 2008). The Cochrane Collaboration, 2008 Available from www.cochrane-handbook.org"},{"issue":"32","key":"10.1002\/14651858.CD006403.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1016\/S0264-410X(01)00234-1","article-title":"In vitro correlate of immunity in a rabbit model of inhalational anthrax","volume":"19","author":"Pitt","year":"2001","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD006403.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infection and Immunity"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0030|cit30","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2008"},{"key":"10.1002\/14651858.CD006403.pub2-BIB0031|cit31","first-page":"61","article-title":"Anthrax","volume-title":"Immunisation against infectious disease","author":"Salisbury","year":"1996"},{"issue":"1","key":"10.1002\/14651858.CD006403.pub2-BIB0032|cit32","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000975.pub2","article-title":"Vaccines for preventing anthrax","author":"Jefferson","year":"1998","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006403.pub2-BIB0033|cit33","article-title":"Vaccines for preventing anthrax","author":"Jefferson","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006403.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:58:55Z","timestamp":1628531935000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006403.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,15]]},"references-count":33,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006403.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,15]]}}}